Export 148 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
C. Gurgol, Foley, A., Belt, P., Denzen, E., Duffy, S., Gallagher, C., Grodman, C., Horowitz, M., Confer, D., and Carter, S., “Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster).”, in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
A. Guimarães-Walker, Mackie, N., McCormack, S., Hanke, T., Schmidt, C., Gilmour, J., Barin, B., McMichael, A., Weber, J., Legg, K., Babiker, A., Hayes, P., Gotch, F., Smith, C., Dally, L., Dorrell, L., Cebere, I., Kay, R., Winstone, N., Moore, S., Goonetilleke, N., and Fast, P., “Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers.”, Vaccine, vol. 26, no. 51, pp. 6671-7, 2008.
A. Guimarães-Walker, Mackie, N., McMichael, A., Weber, J., McCormack, S., Cebere, I., Kay, R., Hanke, T., Dally, L., Gibiansky, L., Legg, K., DeSouza, C., Hayes, P., Gilmour, J., and Fast, P., “Priming with a candidate HIV-1 clade A DNA vaccine followed by boosting with an HIV-1 Clade A MVA vaccine in volunteers at low risk of HIV infection”, 2004.
D. Gu, Mao, Y., Tang, Z., Montaner, J., Shen, Z., Zhu, Q., Detels, R., Jin, X., Xiong, R., Xu, J., Ling, W., Erinoff, L., Lindblad, R., Liu, D., Van Veldhuisen, P., Hasson, A., and Wu, Z., “Loss to Follow-Up from HIV Screening to ART Initiation in Rural China.”, PLoS One, vol. 11, no. 10, p. e0164346, 2016.
J. Gryczynski, McNeely, J., Wu, L. - T., Subramaniam, G. A., Svikis, D. S., Cathers, L. A., Sharma, G., King, J., Jelstrom, E., Nordeck, C. D., Sharma, A., Mitchell, S. G., O'Grady, K. E., and Schwartz, R. P., “Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.”, J Gen Intern Med, vol. 32, no. 9, pp. 990-996, 2017.
T. S. S. R. Group., “SCORE Study Report 5: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid f”, Archives of Ophthalmology, vol. 127, pp. 1101-1114, 2009.
“A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.”, Arch Ophthalmol, vol. 119, no. 10, pp. 1439-52, 2001.
“Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes.”, Transplantation, vol. 72, no. 3, pp. 463-76, 2001.
T. Age Relate Group, Huynh, N., Nicholson, B. P., Agron, E., Clemons, T. E., Bressler, S. B., Rosenfeld, P. J., and Chew, E. Y., “Visual Acuity After Cataract Surgery in Patients with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 5”, Ophthalmology, vol. 121, pp. 1229-1236, 2014.
A. - R. Eye Diseas Group, “Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study. AREDS Report No. 13”, Archives of Ophthalmology, vol. 122, pp. 716-726, 2004.
A. - R. Eye Diseas Group, “Extension of the Wisconsin Lens Opacity Grading System.”, 1997.
“The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6.”, Am J Ophthalmol, vol. 132, no. 5, pp. 668-81, 2001.
theS. P. L. I. T. Rese Group, “Studies in pediatric liver transplantation (SPLIT): Year 2000 outcomes”, Transplantation, vol. 72, pp. 463-76, 2001.
A. - R. Eye Diseas Group, “Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases”, 1998.
“Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5.”, Ophthalmology, vol. 108, no. 8, pp. 1400-8, 2001.
A. - R. Eye Diseas Group, “Potential public health impact of Age-Related Eye Disease Study results. AREDS Report No.11”, Arch Ophthalmol, vol. 121, pp. 1621-1624, 2003.
A. - R. Eye Diseas Group, “Development and validation of a food frequency questionnaire in a randomized trial of eye diseases”, 1999.
“A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.”, Arch Ophthalmol, vol. 119, no. 10, pp. 1417-36, 2001.
A. - R. Eye Diseas Group, “Risk factors associated with age-related nuclear and cortical cataract - A case-control study in the age-related eye disease study. AREDS Report No. 5”, Ophthalmology, vol. 108, pp. 1400-8, 2001.
A. - R. Eye Diseas Group, “The Age-Related Eye Disease Study: A clinical trial of zinc and antioxidants - Age-Related Eye Disease Study Report No. 2”, J Nutrition, vol. 130, p. 1516S-19S, 2000.
P. K. C. - D. R. S. Group, Aiello, L., Davis, M., Girach, A., Kles, K., Milton, R., Sheetz, M., Vignati, L., and Zhi, X., “Effect of Ruboxistaurin on Visual Loss in Patients With Diabetic Retinopathy”, Ophthalmology, vol. 113, pp. 2221-2230, 2006.
A. - R. Eye Diseas Group, Chew, E., Clemons, T. E., SanGiovanni, J. P., Danis, R., ,, Elman, M., Antoszyk, A., Ruby, A., Orth, D., Bressler, S., Fish, G., Hubbard, G., Klein, M., Chandra, S., ,, and Sperduto, R., “Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS 2 Report Number 3”, JAMA Ophthalmol, vol. 132, pp. 142-149, 2014.
S. Outcomes R. Group, “Palivizumab prophylaxis of respiratory syncytial virus (RSV) - results from the 2000-2001 Synagis Outcomes Registry”, Pediatr Pulmonol, vol. 35, pp. 484-9, 2003.
“The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4.”, Am J Ophthalmol, vol. 131, no. 2, pp. 167-75, 2001.
A. - R. Eye Diseas Group, “The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The Age-Related Eye Disease Study Report Number 6”, Am J Ophthalmol, vol. 132, pp. 668-81, 2001.